https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/research-suggests-need-long-term-follow-patients-kawasaki-disease/
Research suggests need for long-term follow-up for patients with Kawasaki Disease
9 Sep 2015, 4:57 p.m.
Kawasaki disease is a rare condition that causes blood vessels to become inflamed and swollen. It predominantly occurs in children under the age of five. If left untreated, it results in balloon-like swellings (aneurysms) in the coronary vessels of approximately 25% of cases. To date, the cause of this disease remains unknown. A group of researchers led by Dr Paul Brogan recently conducted a study aiming to shed light on how the disease develops. Ninety-two children with KD were examined at the Somers Clinical Research Facility (CRF) at GOSH. Levels of circulating endothelial cells (CECs), which are mature cells that have become detached from the vessel wall and are often associated with vascular injury, were measured years after patients developed KD.
The researchers found CECs were elevated in KD patients, usually highest in patients with coronary artery aneurysms. Elevated levels of CECs were also seen in some KD patients that had not had coronary artery aneurysms. While the relevance of elevated CECs are not yet known, this study provides rationale for long-term follow up of these patients.
This study has been accepted for publication in the journal, Heart. It was conducted at the BRC-supported Somers CRF at GOSH. Dr Brogan is a BRC-supported researcher.

Young people donate tissue samples to unlock mysteries of arthritis
A new groundbreaking study led by researchers at the University of Birmingham, Great Ormond Street Hospital, University College London and Birmingham Children’s Hospital has revealed important clues into what is driving arthritis in children.

Toddler doing well after receiving newest gene therapy available on NHS
A toddler with a life-limiting and life-threatening rare disease is the youngest to be treated with the newest gene therapy available on the NHS at GOSH.

Genes may help to predict which children will respond well to arthritis treatment
A team of researchers at Great Ormond Street Hospital (GOSH) and University College London (UCL) have identified a set of genes that could be used to help doctors predict which children will respond well to treatment for juvenile idiopathic arthritis.

Making it easier to invest in frontline care
GOSH and UCL have signed a landmark agreement to simplify the commercialisation of any joint research and innovation and ensure any financial proceeds are shared equally.